Malaria News and Research

Latest Malaria News and Research

Research uncovers an unexpected role for immune T cells in protection against malaria

Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically.

23 Jul 2021

Scientists seek to block pathogen’s most reliable weapon to cause severe malaria

The parasites that cause severe malaria are well-known for the sinister ways they infect humans, but new research may lead to drugs that could block one of their most reliable weapons: interference with the immune response.

21 Jul 2021

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

A multinational research group has been the first to show the excellent activity of artemisinin-based treatment against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cell lines – including a specific type of lung cells. Their findings were recently published in the journal Scientific Reports.

19 Jul 2021

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

19 Jul 2021

Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

A new study has been published in Science Advances that exploits proteomics datasets to develop an agnostic network for SARS-CoV-2–induced pathways, thereby unveiling novel targets and potential repurposing strategies.

7 Jul 2021

Simple blood tests may help prevent inaccuracy in the diagnosis of severe malaria

Using simple blood tests could help researchers identify children who have been misidentified as having severe malaria, according to a study published today in eLife.

6 Jul 2021

Two chemoattenuated PfSPZ malaria vaccines provide strong and lasting protection

A team of researchers recently optimized regimens for CVac, wherein aseptic, purified, cryopreserved, and infectious PfSPZ were inoculated and mixed with PYR and CQ.

5 Jul 2021

Inadequate exposure to UVB light may be linked with increased risk of colorectal cancer

Inadequate exposure to UVB light from the sun may be associated with an increased risk of colorectal cancer, particularly in older age groups, according to a study using data on 186 countries, published in the open access journal BMC Public Health.

5 Jul 2021

New malaria vaccine is undergoing Phase 1 trials but current results show it provides strong and long-lasting protection

A new malaria vaccine could be the breakthrough in developing an effective and lasting treatment.

1 Jul 2021

Researchers identify proteins that contribute to the pathogenicity of COVID-19 virus

Researchers at Texas Biomedical Research Institute (Texas Biomed) have narrowed down the proteins enabling SARS-CoV-2 to cause disease.

1 Jul 2021

Novel candidate malaria vaccine confers high levels of durable protection

Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites.

30 Jun 2021

Sanaria researchers make progress in the development of highly protective malaria vaccine

Researchers from Sanaria Inc. and the National Institutes of Health are making progress in the development of highly protective malaria vaccines.

30 Jun 2021

Six antibody features could be used to identify women at risk of placental malaria

Six antibody characteristics could help scientists identify which pregnant women are at risk of placental malaria infections, finds a study published today in eLife.

29 Jun 2021

Researchers examine whether community administration of ivermectin influences malaria transmission

Researchers from the LSTM based Cochrane Infectious Disease Group explored whether community administration of ivermectin influences malaria transmission.

29 Jun 2021

Rapid test kit for malaria delivers results in 30 minutes

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a test kit for malaria that delivers results in 30 minutes. The kit could facilitate the diagnosis of malaria in the field, as the equipment needed is anticipated to be lightweight, easy-to-use, and able to detect the disease in its early stages.

29 Jun 2021

Malaria News and Research

Latest Malaria News and Research

Research uncovers an unexpected role for immune T cells in protection against malaria

Scientists seek to block pathogen’s most reliable weapon to cause severe malaria

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

Simple blood tests may help prevent inaccuracy in the diagnosis of severe malaria

Two chemoattenuated PfSPZ malaria vaccines provide strong and lasting protection

Inadequate exposure to UVB light may be linked with increased risk of colorectal cancer

New malaria vaccine is undergoing Phase 1 trials but current results show it provides strong and long-lasting protection

Researchers identify proteins that contribute to the pathogenicity of COVID-19 virus

Novel candidate malaria vaccine confers high levels of durable protection

Sanaria researchers make progress in the development of highly protective malaria vaccine

Six antibody features could be used to identify women at risk of placental malaria

Researchers examine whether community administration of ivermectin influences malaria transmission

Rapid test kit for malaria delivers results in 30 minutes

First CRISPR-Cas9-based gene drive cuts and copies genetic elements in Arabidopsis plants

Researchers identify key role of enzyme essential for invasion of the toxoplasmosis parasite

Natural compound myricetin shows antiviral potential against SARS-CoV-2

WHO estimates suicide as one of the leading causes of death

Deep learning could transform the ability to accurately interpret HIV test results

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Malaria News and Research

Latest Malaria News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in